Patents Assigned to GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
  • Patent number: 11786924
    Abstract: Aspects of the present invention are directed to a variable dose container. The variable dose container may comprise a container including a top portion, a bottom portion, and a side wall portion, the space between the bottom portion and the side wall portion defining an interior space, wherein the container stores contents within the interior space. The variable dose container may further include an actuator coupled with the top portion of the container that is depressible in a longitudinal direction to drive the contents held in the interior space of the container out of a nozzle protruding horizontally from the actuator. Additionally, the variable dose container may include a collar under the nozzle, a top circumferential edge of the collar containing one or more grooves of varying depth into which the nozzle can be inserted when depressed, thereby adjusting a distance the actuator is moved in the longitudinal direction.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: October 17, 2023
    Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
    Inventors: Amit Sabherwal, Gregory Ornoski
  • Patent number: 11679139
    Abstract: A liquid composition comprising witch hazel; glycerin; dehydrated xanthan gum; and water.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: June 20, 2023
    Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
    Inventors: Shivangi Akash Patel, Renee Nelson
  • Patent number: 11510856
    Abstract: The invention provides a topical o/w emulsion which moisturizes, and protects, repairs or restores the skin lipid barrier of a mammal. The topical o/w emulsion composition comprises: a) a discontinuous oil phase; b) a continuous aqueous phase comprising water; c) a thickening agent; d) at least one lamellar membrane structure comprising (i) a phospholipid, (ii) a fatty alcohol, and (iii) a fatty acid; e) a pharmaceutically acceptable active agent; and f) optionally a dermatologically acceptable excipient. In one embodiment, the composition, in use, has a water vapor transmission rate of less than or about 75 g·m?2·hr?1 measured in vitro using the modWVTR test methodology.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: November 29, 2022
    Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
    Inventors: Pallav Arvind Bulsara, Martyn J. Clarke, Dara Lisa Dinner, Alireza Shalviri
  • Patent number: 11433037
    Abstract: Aspects of the present invention are directed to an oral dosage form comprising a core containing one more active ingredients and a fast-release exterior coating. The fast release exterior coating includes a water soluble polymer; a saccharide or sugar alcohol, or a combination thereof, and a flavoring. The flavoring may be a warming sensate that is released in the oral cavity of the user after inserting the dosage form in his or her mouth.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: September 6, 2022
    Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
    Inventor: Christopher Joseph Pulford
  • Patent number: 11399575
    Abstract: Embodiments can provide a wearable device for nicotine cessation behavioral support, comprising a top surface; a first surface; a second surface; an underside surface; a communication device; one or more buttons; an internal storage medium; and a power supply; wherein the one or more buttons are configured to log a NRT use event to the internal storage medium when depressed and subsequently released within a predetermined timeframe; wherein the one or more buttons are configured to log a tobacco use event to the internal storage medium when depressed and released at a time longer than the predetermined timeframe; wherein the one or more buttons, when depressed, are configured to log a craving event to the internal storage medium, wherein an intensity of the craving event is determined by a time duration between depression and release of the one or more buttons.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: August 2, 2022
    Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Patent number: 10881582
    Abstract: Aspects of the present invention are directed to an individual dose pack. The individual dose pack may comprise a single serving pod and an overwrap surrounding the entirety of the single serving pod and sealing the single serving pod therein, wherein the overwrap is child-resistant and creates an impermeable barrier being resistant to the passage of liquids and gases. The single serving pod may include a cup, at least one pharmaceutical active ingredient provided in the cup, and a lid affixed to the cup. The overwrap is a multi-layer structure including a first layer being a biaxially-oriented polyethylene terephthalate layer, a second layer being a polyethylene layer, a third layer being an aluminum foil layer, and fourth layer being an ionomer layer.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: January 5, 2021
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Sriman Banerjee, Kathryn Cramer, Gautam Debnath
  • Patent number: 10350238
    Abstract: An oral care compositon is described for use in the treatment or alleviation of the symptoms of dry mouth comprising polyvinyl pyrrolidone (PVP) or a derivative thereof, an anionic mucoadhesive polymer and an orally acceptable carrier or excipient.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: July 16, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Gertrud Kawa, Shireen Uppal, David Urquhart
  • Patent number: D796335
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: September 5, 2017
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventor: Amit Sabherwal
  • Patent number: D818818
    Type: Grant
    Filed: January 16, 2017
    Date of Patent: May 29, 2018
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings, US, LLC
    Inventors: Gautam Debnath, Jeffrey Scott Brunner
  • Patent number: D842719
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: March 12, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Patent number: D842720
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: March 12, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Patent number: D854542
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: July 23, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Patent number: D856793
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: August 20, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Gautam Debnath, Jeffrey Scott Brunner
  • Patent number: D868780
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: December 3, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Patent number: D958645
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: July 26, 2022
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Gautam Debnath, Jeffrey Scott Brunner